1. HBW Insight

Sanofi Secures First EU Market Approval for OTC Cialis

 
• By Tom Gallen

Following an application through the decentralised procedure, Ireland is the first EU member state to approve Sanofi's Cialis (tadalafil) for non-prescription sale. An OTC version of the blockbuster erectile dysfunction treatment has also been given the green light in Norway, but Germany has rejected the product.

• Source: Shutterstock

Sanofi Consumer Healthcare is set to introduce to the European Union a new OTC option for erectile dysfunction sufferers after securing approval to launch non-prescription Cialis (tadalafil) in Ireland.

Ireland’s Health Products Regulatory Authority granted a marketing authorization for Cialis For Men 10 mg film-coated tablets on 1 December following a successful application through the decentralised

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Innovation & IP

More from Health